XOFLUZA
Film-coated tablet, 40 mg
RxActive license
Active substance (INN)
baloxavir marboxil
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength40 mg
PackagingUkupno 1 film tableta u blisteru (1x1) u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAnti-infectives for systemic use (J05AX25)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateApril 16, 2024
Analogs in Montenegro
3Other medicines with the same active substance
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026